With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Identification of Mechanisms of Resistance to Trametinib Monotherapy in PAX-fusion Negative Rhabdomyosarcoma||National Cancer Institute / Marielle Yohe, MD/PhD||Young Investigator Grants||2016||Maryland|
|Pre-clinical Testing of Novel Glutamine Metabolic Inhibitors in MYC-driven Medulloblastoma||The Johns Hopkins University School of Medicine / Eric Raabe, MD/PhD & Dr. Barbara Slusher, PhD||Innovation Grants||2016||Maryland|
|Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML||Boston Children's Hospital / Alan Cantor, MD, PhD||Familial RUNX1 Research Grants||2016||Massachusetts|
|GeneEditing in T cell Leukemia to Promote Immunomodulatory Forms of Cell Death||Boston Children's Hospital / Dr. Ben Croker, PhD||Innovation Grants||2016||Massachusetts|
|Targeted Inhibition of Lin28/let-7 Binding to Treat Pediatric Malignancy||Boston Children's Hospital / George Q. Daley, MD/PhD||Innovation Grants||2016||Massachusetts|
|Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma||Dana-Farber Cancer Institute / David Debruyne, PhD||Young Investigator Grants||2016||Massachusetts|
|A Role for Non-canonical Wnt/PCP Signaling in Growth and Self-Renewal of Embryonal Rhabdomyosarcoma||Massachusetts General Hospital / Madeline Hayes, PhD||Young Investigator Grants||2016||Massachusetts|
|Redefining the Cellular Architecture of Diffuse Intrinsic Pontine Glioma through Large-Scale Single-cell RNA-seq Analyses||Massachusetts General Hospital / Mario Suva, MD/PhD||Innovation Grants||2016||Massachusetts|
|The Role of ARID1A in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Hui Shi, PhD||Young Investigator Grants||2016||Massachusetts|
|Resistance and Develop Improved Treatments for Relapsed/refractory Pediatric ALL||Dana-Farber Cancer Institute / Elizabeth Townsend, PhD||Young Investigator Grants||2016||Massachusetts|